Robotic sampling devices find pharma compounds in marine water
Scientists in Europe have proposed a cost-effective way of monitoring chemicals in EU waters - including pharmaceuticals - using unmanned sampling devices.
Archives for March 15, 2016
China modifies bioequivalence testing rules and sets new deadlines
Generic drugs in China must demonstrate bioequivalence (BE) to branded medicines under new CFDA rules prohibiting the use of locally-made generics as reference products.
Pfizer to invest $21m in Australian filgrastim plant
Pfizer has said it will invest $21m to expand a plant in Adelaide, Australia which will manufacture a candidate biosimilar version of Amgen’s white blood cell booster, Neulasta.
Sanofi aiming to 'cut years off' vaccine development timelines for Zika says R&D head
Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
Samsara Sciences signs up QPS as liver cell distributor
QPS Holdings will distribute liver cells made by Samsara Sciences under a deal agreed last week.
CHO business: Lonza launches reformulated media for biopharma's go-to cell line
Lonza has launched a reformulated CHO media that it says supports the growth of higher density cultures and is easier to filter than currently available products.
MannKind's troubles trickle-down to hit insulin API supplier Amphastar
Amphastar has predicted last year’s insulin API sales growth will not be repeated in 2016 due to uncertain demand from Afrezza maker MannKind.
Amgen selects Patheon as a 'strategic' manufacturing partner
The flexible manufacturing deal with Amgen is a departure from the standard transactional contract approach, according to Patheon.